Samrat Pharmachem News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Samrat Pharmachem from all sources in a single place.

29 Dec 2025

227.15

-3.22%

Board Meeting

Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter …

BSE India

Samrat Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the un-audited financial results for the quarter ended December 31, 2025

pdf

Samrat Pharmachem Ltd.

29 Dec 2025

227.15

-3.22%

SAST

Samrat Pharmachem Ltd-$ - 530125 - Closure of Trading Window

BSE India

The Trading Window of the Company shall remain closed from Thursday, January 1, 2026 till 48 hours after the declaration of Un-audited financial results for the quarter ended December 31, 2025.

pdf

Samrat Pharmachem Ltd.

02 Dec 2025

227.15

-3.22%

Company Update

Samrat Pharmachem Ltd-$ - 530125 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Crisil Ltd has downgraded its rating to "CrisilBB+/Negative/CrisilA4+"

pdf

Samrat Pharmachem Ltd.

20 Nov 2025

227.15

-3.22%

Company Update

Samrat Pharmachem Ltd-$ - 530125 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication - Extract of Results for the quarter and half year ended September 30, 2025

pdf

Samrat Pharmachem Ltd.

14 Nov 2025

227.15

-3.22%

Result

Samrat Pharmachem Ltd-$ - 530125 - Un-Audited Financial Results For The Quarter And Half Year Ended …

BSE India

Un-audited financial results for the quarter and half year ended 30th September, 2025

pdf

	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	78.92	76.34	70.66	3.4%	11.7%
Operating Profit Qtr	-0.36	0.12	3.36	-400.0%	-110.7%
Net Profit Qtr	-0.59	-0.23	2.66	-156.5%	-122.2%
Earning Per Share Adjusted latest Qtr	-1.90	-0.74	8.61	-156.8%	-122.1%

* Standalone data

Detailed Results

Samrat Pharmachem Ltd.

14 Nov 2025

227.15

-3.22%

Board Meeting

Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Outcome for Outcome Of Board Meeting Held Today

BSE India

The Board of Directors considered and took on record the Un-audited Standalone Financial Results for the quarter and half year ended September 30, 2025.

pdf

Samrat Pharmachem Ltd.

10 Oct 2025

227.15

-3.22%

Company Update

Samrat Pharmachem Ltd-$ - 530125 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under reg. 74(5) for the quarter ended September 30, 2025

pdf

Samrat Pharmachem Ltd.

27 Sep 2025

227.15

-3.22%

Corp. Note

Samrat Pharmachem Ltd-$ - 530125 - Corporate Action-Board approves Dividend

BSE India

The shareholders approved the dividend on equity shares for the FY: 2024-25 @ Re. 1/- per share of Rs. 10 each (10%)

pdf

Samrat Pharmachem Ltd.

27 Sep 2025

227.15

-3.22%

AGM

Samrat Pharmachem Ltd-$ - 530125 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Scrutinizer Report & Voting Results for 33 AGM

pdf

Samrat Pharmachem Ltd.

26 Sep 2025

227.15

-3.22%

Board Meeting

Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter …

BSE India

Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Un-audited financial results for the quarter ended September 30, 2025

pdf

Is Samrat Pharmachem Ltd. worth buying?

47 Votes:

Buy 68.09%

Sell 12.77%

Hold 19.15%